Bulk funded for FY17 - drug: prolastin
Ended Awarded Last action
- Contract number
- VA26017J0022
- Awardee
-
Grifols Therapeutics LLC UEI UFQ3A7GKJ5C7
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $66,720
Award facts
- Contract value 100% obligated
- $66,720.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Walla Walla, WA 99362, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$1,800 | |
| Original award | $68,520 |
Quick answers
Who was awarded contract VA26017J0022?
VA26017J0022 was awarded to Grifols Therapeutics LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 6, 2016.
How much is contract VA26017J0022 worth?
The government has obligated $66,720 on VA26017J0022.
Is contract VA26017J0022 an order under another contract?
Yes. VA26017J0022 is a BPA call under V797D30042-VA797P13A0002, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA26017J0022 competed?
The extent of competition for VA26017J0022 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award